Computed tomographic perfusion imaging for the prediction of response and survival to transarterial chemoembolization of hepatocellular carcinoma Cover

.blurhash-client-img { display: none !important; }

Computed tomographic perfusion imaging for the prediction of response and survival to transarterial chemoembolization of hepatocellular carcinoma

Radiology and Oncology

Volume 52 (2018): Issue 1 (March 2018)

By: Peter Popovic, Ana Leban, Klara Kregar, Manca Garbajs, Rok Dezman and Matjaz Bunc

Open Access

|Dec 2017

Authors

Peter Popovic

peter.popovic@kclj.si

Clinical Institute of Radiology, University Medical Centre, Ljubljana, Slovenia

Ana Leban

General Hospital Dr. Franca Derganca, Šempeter pri Gorici, Slovenia

Klara Kregar

General Hospital Jesenice, Jesenice, Slovenia

Manca Garbajs

Clinical Institute of Radiology, University Medical Centre, Ljubljana, Slovenia

Rok Dezman

Clinical Institute of Radiology, University Medical Centre, Ljubljana, Slovenia

Matjaz Bunc

Department of Cardiology, University Medical Centre, Ljubljana, Slovenia

DOI: https://doi.org/10.1515/raon-2017-0052 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 14 - 22

Submitted on: Sep 11, 2017

|

Accepted on: Oct 15, 2017

|

Published on: Dec 7, 2017

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

hepatocellular carcinoma,

computed tomography perfusion imaging,

drug-eluting beads transarterial chemoembolization,

response to treatment,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2017 Peter Popovic, Ana Leban, Klara Kregar, Manca Garbajs, Rok Dezman, Matjaz Bunc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 52 (2018): Issue 1 (March 2018)Next article